30 Sept 2026, 09:57
Company UpdateMS
IBXIMAGION BIOSYSTEMS LIMITED
Announcement history available from 1 August 2025
Fromto
14 Sept 2026, 09:03
Company UpdateMS
4 Sept 2026, 09:26
Presentations—
1 Sept 2026, 10:06
Securities Administration—
1 Sept 2026, 10:04
Securities Administration—
1 Sept 2026, 09:59
Securities Administration—
27 Aug 2026, 10:18
Securities Administration—
26 Aug 2026, 09:47
Company UpdateMS
25 Aug 2026, 15:40
Director Interests—
24 Aug 2026, 17:51
Financial ResultsMS
18 Aug 2026, 10:21
Securities Administration—
18 Aug 2026, 10:18
Securities Administration—
18 Aug 2026, 09:30
Securities Administration—
18 Aug 2026, 09:29
Securities Administration—
10 Aug 2026, 12:42
Meetings & Governance—
31 July 2026, 09:13
Quarterly ReportsMS
28 July 2026, 15:59
Securities Administration—
28 July 2026, 15:58
Securities Administration—
8 July 2026, 09:32
Presentations—
7 July 2026, 09:39
Company Update—
2 July 2026, 09:33
Securities Administration—
2 July 2026, 09:26
Securities Administration—
1 July 2026, 11:22
Director Interests—
25 June 2026, 14:47
Securities Administration—
25 June 2026, 14:18
Securities Administration—
25 June 2026, 09:29
Securities Administration—
25 June 2026, 09:29
Securities Administration—
25 June 2026, 09:29
Securities Administration—
25 June 2026, 09:28
Capital RaisingMS
23 June 2026, 09:33
Trading Halt / SuspensionMS
12 June 2026, 15:31
Securities Administration—
2 June 2026, 09:05
Company UpdateMS
28 May 2026, 15:00
Securities Administration—
26 May 2026, 15:21
Meetings & Governance—
26 May 2026, 09:45
Presentations—
26 May 2026, 09:42
Letters & Addresses—
8 May 2026, 12:06
Director Interests—
4 May 2026, 12:11
Securities Administration—
24 Apr 2026, 11:16
Meetings & Governance—
23 Apr 2026, 14:39
Securities Administration—
23 Apr 2026, 14:14
Securities Administration—
23 Apr 2026, 12:16
Quarterly ReportsMS
16 Apr 2026, 16:29
Securities Administration—
8 Apr 2026, 10:50
Securities Administration—
7 Apr 2026, 15:08
Meetings & Governance—
2 Apr 2026, 16:09
Securities Administration—
2 Apr 2026, 15:16
Company Administration—
2 Apr 2026, 15:14
Securities Administration—
27 Feb 2026, 14:57
Company Administration—
27 Feb 2026, 14:55
Financial ResultsMS
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 30 Sept 2026, 09:57 | IBX Secures Central Ethics Approval - Key Phase 2 Milestone | Company Update | MS | 11001 | |
| 14 Sept 2026, 09:03 | MagSense Nanoparticle Manufacturing Update | Company Update | MS | 11001 | |
| 4 Sept 2026, 09:26 | IBX Investor Presentation | Presentations | — | 03026 | |
| 1 Sept 2026, 10:06 | Cleansing Notice | Securities Administration | — | 06018 | |
| 1 Sept 2026, 10:04 | Application for quotation of securities - IBX | Securities Administration | — | 06020 | |
| 1 Sept 2026, 09:59 | Application for quotation of securities - IBX | Securities Administration | — | 06020 | |
| 27 Aug 2026, 10:18 | Notification of cessation of securities - IBX | Securities Administration | — | 06027 | |
| 26 Aug 2026, 09:47 | IBX Phase 2 Clinical Trial Update | Company Update | MS | 11001 | |
| 25 Aug 2026, 15:40 | Change of Director's Interest Notices - RP, BM, NW | Director Interests | — | 02009 | |
| 24 Aug 2026, 17:51 | Appendix 4D and Half-yearly Financial Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 18 Aug 2026, 10:21 | Cleansing Notice | Securities Administration | — | 06018 | |
| 18 Aug 2026, 10:18 | Application for quotation of securities - IBX | Securities Administration | — | 06020 | |
| 18 Aug 2026, 09:30 | Cleansing Notice | Securities Administration | — | 06018 | |
| 18 Aug 2026, 09:29 | Application for quotation of securities - IBX | Securities Administration | — | 06020 | |
| 10 Aug 2026, 12:42 | Results of General Meeting | Meetings & Governance | — | 08003 | |
| 31 July 2026, 09:13 | Appendix 4C and Quarterly Activities Report - June 2026 | Quarterly Reports | MS | 19002, 19007 | |
| 28 July 2026, 15:59 | Proposed issue of securities - IBX | Securities Administration | — | 06013 | |
| 28 July 2026, 15:58 | Non-Dilutive Short-Term Funding Secured | Securities Administration | — | 06009 | |
| 8 July 2026, 09:32 | Notice of General Meeting/Proxy Form | Presentations | — | 08004, 08007, 14014, 16002 | |
| 7 July 2026, 09:39 | Imagion Extends Collaboration with Siemens Healthineers | Company Update | — | 11001 | |
| 2 July 2026, 09:33 | Cleansing Notice | Securities Administration | — | 06018 | |
| 2 July 2026, 09:26 | Application for quotation of securities - IBX | Securities Administration | — | 06020 | |
| 1 July 2026, 11:22 | Change of Director's Interest Notices - RP, BM, NW | Director Interests | — | 02009 | |
| 25 June 2026, 14:47 | Notification regarding unquoted securities - IBX | Securities Administration | — | 06021 | |
| 25 June 2026, 14:18 | Update - Proposed issue of securities - IBX | Securities Administration | — | 06013 | |
| 25 June 2026, 09:29 | Proposed issue of securities - IBX | Securities Administration | — | 06013 | |
| 25 June 2026, 09:29 | Proposed issue of securities - IBX | Securities Administration | — | 06013 | |
| 25 June 2026, 09:29 | Proposed issue of securities - IBX | Securities Administration | — | 06013 | |
| 25 June 2026, 09:28 | IBX Secures Firm Commitments for $3.75m for Clinical Trial | Capital Raising | MS | 06003, 09014 | |
| 23 June 2026, 09:33 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 12 June 2026, 15:31 | Notification of cessation of securities - IBX | Securities Administration | — | 06027 | |
| 2 June 2026, 09:05 | Imagion Biosystems Receives IND Clearance from US FDA | Company Update | MS | 11001 | |
| 28 May 2026, 15:00 | Notification of cessation of securities - IBX | Securities Administration | — | 06027 | |
| 26 May 2026, 15:21 | Results of Annual General Meeting | Meetings & Governance | — | 08003 | |
| 26 May 2026, 09:45 | Investor Presentation | Presentations | — | 03026 | |
| 26 May 2026, 09:42 | IBX Chairman's AGM Address | Letters & Addresses | — | 15002 | |
| 8 May 2026, 12:06 | Change of Director's Interest Notice - Robert Proulx | Director Interests | — | 02009 | |
| 4 May 2026, 12:11 | Notification of cessation of securities - IBX | Securities Administration | — | 06027 | |
| 24 Apr 2026, 11:16 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 23 Apr 2026, 14:39 | Notification regarding unquoted securities - IBX | Securities Administration | — | 06021 | |
| 23 Apr 2026, 14:14 | Cleansing Statement - Section 708A(12C)(e) | Securities Administration | — | 06018 | |
| 23 Apr 2026, 12:16 | Appendix 4C and Quarterly Activities Report - March 2026 | Quarterly Reports | MS | 19001, 19006 | |
| 16 Apr 2026, 16:29 | Proposed issue of securities - IBX | Securities Administration | — | 06013 | |
| 8 Apr 2026, 10:50 | IBX Update Regarding Short Term Funding Facilities | Securities Administration | — | 06009 | |
| 7 Apr 2026, 15:08 | Date of AGM and Closing Date for Director Nominations | Meetings & Governance | — | 08006 | |
| 2 Apr 2026, 16:09 | Notification of cessation of securities - IBX | Securities Administration | — | 06027 | |
| 2 Apr 2026, 15:16 | Appendix 3H Lodged Late - Part Repayment of Convertible Note | Company Administration | — | 06009, 12008 | |
| 2 Apr 2026, 15:14 | Notification of cessation of securities - IBX | Securities Administration | — | 06027 | |
| 27 Feb 2026, 14:57 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 27 Feb 2026, 14:55 | FY25 Appendix 4E and Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 |
1–50 of 91
1 / 2